Medical Weight Loss for Merrimack, New Hampshire Residents

Merrimack, New Hampshire residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Merrimack through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Merrimack: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps New Hampshire patients choose. Doctor review just $119 (medication separate).

Why Merrimack Residents Choose New Hope Weight Loss

Some patients in Merrimack are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

Medical weight loss for Merrimack is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Our clinic sits in Costa Mesa, California, but if you live in Merrimack, New Hampshire, you receive the exact same physician-supervised care from Dr. Anjmun Sharma over telehealth, with no drive and no waiting room. We care for patients throughout Merrimack and the greater Hillsborough County area between Nashua and Manchester. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in New Hampshire.

Patients on the outskirts of New Hampshire get the same flat pricing, the same physician, and the same fast start as those near the center of Merrimack. Tirzepatide, which shares its active ingredient with Mounjaro and Zepbound, starts at $233 per month for Merrimack patients and is billed apart from the $119 visit. New Hope Weight Loss reaches patients all across New Hampshire by secure telehealth from our Costa Mesa, California clinic, delivering physician-supervised care without any travel.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Merrimack telehealth visits.

How Telehealth Works for Merrimack

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Merrimack address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Merrimack

How does someone in Merrimack access New Hope Weight Loss?

Access from Merrimack is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Merrimack, New Hampshire through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Merrimack residents?

A clinic visit is never part of it for Merrimack. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Merrimack inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Merrimack patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Merrimack residents are charged no distance surcharge.

What areas of Merrimack do you serve?

We serve patients from across Merrimack by telehealth, including Merrimack and the greater Hillsborough County area between Nashua and Manchester.

What does treatment cost for Merrimack patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Merrimack.

Merrimack Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Merrimack, New Hampshire by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.